← Back to Company DatabaseVisit Website
CancerIQ
Precision prevention platform for hereditary cancer risk assessment.
Series AChicago, ILFounded 2014
About
CancerIQ provides a software platform that helps health systems identify patients at high risk for hereditary cancers and guide them through genetic testing and preventive care. The platform automates risk assessment workflows and integrates with electronic health records. Its goal is to make cancer prevention more accessible and scalable across health systems.
Total Funding
$18MKey Product
CancerIQ precision cancer prevention platformGeography
North AmericaKey Investors
OMERS VenturesAmgen VenturesBlueCross BlueShield Venture Partners
Focus Areas
Early Detection / ScreeningPatient Navigation / SupportData / Analytics
Technology
Digital Health / SoftwareGenomics / Sequencing
Cancer Types
BreastPan-cancer
Last updated: Feb 4, 2026